Novel bicyclic nucleoside analogue (1S,5S,6S)-6- hydroxy-5-hydroxymethyl-1-(uracil-1-yl)-3,8-dioxabicyclo[3.2.1]octane: synthesis and incorporation into oligodeoxynucleotides

The novel bicyclic nucleoside (1S,5S,6S)-6-hydroxy-5-hydroxymethyl-1-(uracil-1-yl)-3,8-dioxabicyclo[3.2.1]octane [2'-deoxy-1'-C,4'-C-(2-oxapropano)uridine] (15), expected to be restricted into an O4'-endo furanose conformation, was synthesized from the known 1-(3'-deoxy-beta-D-psicofuranosyl)uracil 5. The phosphoramidite derivative of 15 was successfully incorporated into oligodeoxynucleotides using standard methods, and thermal denaturation studies showed moderate decreases in duplex stabilities of -2.1 and -1.5 degrees C per modification toward complementary DNA and RNA, respectively.     

Diastereoselective hydroxylation of 6-substituted piperidin-2-ones. An efficient synthesis of (2S,5R)-5-hydroxylysine and related alpha-amino acids

The synthesis of (2S,5R)-5-hydroxy-6-oxo-1,2-piperidinedicarboxylates (5) and related (3S,6R)-3-hydroxy-6-alkyl-2-oxo-1-piperidinecarboxylates has been developed. The approach is based on the asymmetric hydroxylation of enolates generated from the corresponding N-protected-6-substituted piperidin-2-ones. The utility of 5a as a precursor in the synthesis of (2S,5R)-5-hydroxylysine (1), an amino acid unique to collagen and collagen-like proteins, has also been demonstrated. (2S)-6-oxo-1,2-piperidinedicarboxylates (6) required for hydroxylation studies were prepared in 38-74% yield, starting from conveniently protected aspartic acid as inexpensive chiral adduct. Hydroxylation of 6 to 5 proceeds in high yield and excellent diastereoselectivity by treatment of their Li-enolate with (+)-camphorsulfonyloxaziridine at -78 degrees C. Ring opening of di-tert-butyl (2S,5R)-6-oxo-1,2-piperidinedicarboxylate ((5R)-5a) under reductive conditions afforded the corresponding 1,2-diol (17) in 91%, which was further transformed to (2S,5R)-5-hydroxylysine in four steps (84%). 17 is also a versatile intermediate in the preparation of tert-butyl (2S,5R)-2-[(tert-butoxycarbonyl)amino]-5-hydroxy-6-iodohexanoate (3) and tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-4-[(2R)-oxiranyl]butanoate (4), two amino acid derivatives used in the total synthesis of the bone collagen cross-link (+)-pyridinoline (2a).     

Convenient synthesis of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4- chlorophenyl）-6-（hydroxymethyl）-tetrahydro- 2H-pyran-3,4,5-triol

A convenient approach for the preparation of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4-chlorophenyl）-6-（hydroxymethyl）- tetrahydro-2H-pyran-3,4,5-triol I is developed. The target compound via four steps is synthesized from 4-bromo-2-（bromomethyl）- 1-chlorobenzene and the isomers of undesired ortho-products were avoided during the preparation.     

Synthesis and activity of a metabolite of (S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4-(1H,3H)-pyrimidinedione (CX-659S)

CX-659S (1) [(S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4-(1H,3H)-pyrimidinedione], has been developed as a new type anti-inflammatory agent for the treatment of dermatitis. The structure of a major metabolite of CX-659S was determined as (S)-6-amino-5-[2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadienyl)butanamide]-3-methyl-1-phenyl-2,4-(1H,3H)-pyrimidinedione (2) by direct comparison with the synthesized authentic compound. The anti-inflammatory activity of 2 was equipotent with that of 1 on the contact hypersensitivity reaction (CHR) induced by picryl chloride (PC) in mice, suggesting that compound 2 contributes, at least in part, to the anti-inflammatory activity of CX-659S.     

A Short and Stereoselective Synthesis of the （-）-（5R, 6S）-6-Acetoxy-hexadecane-5-olide

(-)-(5R, 6S)-6-Acetoxyhexadecan-5-olide 1, a natural mosquito attractant pheromone,was synthesized from readily available aldehyde 2 and cyclopentanone 3 using L-proline-catalyzed asymmetric aldol reaction as the key step.     

Photoelectron spectroscopy and theoretical studies of UF5(-) and UF6(-)

The UF(5)(-) and UF(6)(-) anions are produced using electrospray ionization and investigated by photoelectron spectroscopy and relativistic quantum chemistry. An extensive vibrational progression is observed in the spectra of UF(5)(-), indicating significant geometry changes between the anion and neutral ground state. Franck-Condon factor simulations of the observed vibrational progression yield an adiabatic electron detachment energy of 3.82 ± 0.05 eV for UF(5)(-). Relativistic quantum calculations using density functional and ab initio theories are performed on UF(5)(-) and UF(6)(-) and their neutrals. The ground states of UF(5)(-) and UF(5) are found to have C(4v) symmetry, but with a large U-F bond length change. The ground state of UF(5)(-) is a triplet state ((3)B(2)) with the two 5f electrons occupying a 5f(z3)-based 8a(1) highest occupied molecular orbital (HOMO) and the 5f(xyz)-based 2b(2) HOMO-1 orbital. The detachment cross section from the 5f(xyz) orbital is observed to be extremely small and the detachment transition from the 2b(2) orbital is more than ten times weaker than that from the 8a(1) orbital at the photon energies available. The UF(6)(-) anion is found to be octahedral, similar to neutral UF(6) with the extra electron occupying the 5f(xyz)-based a(2u) orbital. Surprisingly, no photoelectron spectrum could be observed for UF(6)(-) due to the extremely low detachment cross section from the 5f(xyz)-based HOMO of UF(6)(-).     

Synthesis and modeling study of (2S,5R,6R)- and (2S,5R,6S)-6-hydroxy- 8-(1-decynyl)-benzolactam-V8 as protein kinase C modulators

[structures: see text] Both (2S,5R,6R)- and (2S,5R,6S)-6-hydroxy-8-(1-decynyl)benzolactam-V8 were designed and synthesized as PKC modulators. Biological assays reveal the (6R)-ligand to be 20-fold more potent than its (6S)-counterpart in binding to PKC alpha.     

Concise asymmetric synthesis of (5S, 6S)- aeginetolide and (5S)- dihydroactinidiolide

An asymmetric deprotonation reaction allows for short syntheses of the lactones (5S, 6S)- Aeginetolide (1) and (5S)-Dihydroactinidiolide (2).     

Improved preparation of (1S,3’R,4’S,5’S,6’R)-5-chloro-6-[(4-ethylphenyl)methyl]-3’,4’,5’,6’-tetrahydro-6’-(hydroxymethyl)-spiro[isobenzofuran-1(3H),2’-[2H]pyran]-3’,4’,5’-triol

A convenient approach for the preparation of(1S,3’R.4’S,5’S,6’R)-5-chloro-6-[(4-ethylphenyl)methyl]- 3’,4’,5’,6’-tetrahydro-6’-(hydroxymethyl)-spiro[isobenzofuran-1(3H),2’-[2H]pyran]-3’,4’,5’-triol is developed. The targeted compound was synthesized from 2-bromo-4-methylbenzoic acid in nine steps and the isomers of undesired ortho-products were avoided during the preparation.     

Syntheses and structural characterizations of endo-eta(1)-, exo-eta(1)-, eta(4)-, eta(5)-, and eta(6)-metallaphosphamonocarbaborane complexes derived from a versatile new polyborane ligand: exo-6-R-arachno-6,7-PCB(8)H(12)

Deprotonation of the phosphamonocarbaborane, exo-6-R-arachno-6,7-PCB(8)H(12) (R = Ph 1a or Me 1b), yields exo-6-R-arachno-6,7-PCB(8)H(11)(-), which when reacted with appropriate transition-metal reagents affords new metallaphosphamonocarbaborane complexes in which the metals adopt endo-eta(1), exo-eta(1), eta(4), eta(5), or eta(6) coordination geometries bonded to the formal R-arachno-PCB(8)H(11)(-), R-arachno-PCB(8)H(10)(2-), R-arachno-PCB(8)H(9)(3-), or R-nido-PCB(8)H(9)(-) ligands. The reaction of exo-6-(C(6)H(5))-arachno-6,7-PCB(8)H(11)(-) (1a-) with Mn(CO)(5)Br generated the eta(1)-sigma product exo-6-[Mn(CO)(5)]-endo-6-(C(6)H(5))-arachno-6,7-PCB(8)H(11) (2) having the [Mn(CO)(5)] fragment in the thermodynamically favored exo position at the P6 cage atom. On the other hand, reaction of 1a- with (eta(5)-C(5)H(5))Fe(CO)(2)I resulted in the formation of two products, an eta(1)-sigma complex endo-6-[(eta(5)-C(5)H(5))Fe(CO)(2)]-exo-6-(C(6)H(5))-arachno-6,7-PCB(8)H(11) (3) having the (eta(5)-C(5)H(5))Fe(CO)(2) fragment attached at the endo-P6 position and an eta(6)-closo complex, 1-(eta(5)-C(5)H(5))-2-(C(6)H(5))-closo-1,2,3-FePCB(8)H(9) (4a). Rearrangement of the endo-compound 3 to its exo-isomer 5 was observed upon photolysis of 3. Synthesis of the methyl analogue of 4a, 1-(eta(5)-C(5)H(5))-2-CH(3)-closo-1,2,3-FePCB(8)H(9) (4b), along with a double-insertion product, 1-CH(3)-2,3-(eta(5)-C(5)H(5))(2)-2,3,1,7-Fe(2)PCB(8)H(9) (6), containing two iron atoms eta(5)-coordinated to a formal R-arachno-PCB(8)H(9)(3-), was achieved by reaction of exo-6-CH(3)-arachno-6,7-PCB(8)H(11)(-) (1b-) with FeCl(2) and Na(+)C(5)H(5)(-). Complexes 4a and 4b can be considered ferrocene analogues, in which an Fe(II) is sandwiched between C(5)H(5)(-) and 6-R-nido-6,9-PCB(8)H(9)(-) anions. Reaction of exo-6-(C(6)H(5))-arachno-6,7-PCB(8)H(11)(-) (1a-) with cis-dichlorobis(triphenylphosphine)platinum (II) afforded two compounds, an eta(1)-sigma complex with the metal fragment again in the endo-P6 position, endo-6-[cis-(Ph(3)P)(2)PtCl]-exo-6-(C(6)H(5))-arachno-6,7-PCB(8)H(11) (7) and an eta(4)-complex, 7-(C(6)H(5))-11-(Ph(3)P)(2)-nido-11,7,8-PtPCB(8)H(10) (8) containing the formal R-arachno-PCB(8)H(10)(2)(-) anion. The structures of compounds 2, 3, 4a, 4b, 6, 7, and 8 were crystallographically confirmed.     

(3R,4aR,5S,6R)-6-Hydroxy-5-methylramulosin: a new ramulosin derivative from a marine-derived sterile mycelium

(3R,4aR,5S,6R)-6-Hydroxy-5-methylramulosin (1) was isolated from a culture of a sterile mycelium, which was derived from the green alga, Codium fragile, along with (-)-5-methylmellein (2), (-)-5-hydroxymethylmellein (3), and (-)-(3R,4R)-cis-4-hydroxy-5-methylmellein (4). The absolute configuration of 1 was determined by the NMR data along with the lactone sector rule by circular dichroism (CD). Compound 1 exhibited moderate cytotoxic activity against HeLa cells.     

Synthesis and Crystal Structure of 3-（2-Hydroxy-phenyl）-5-（2-methylphenyl）-6-thoxycarbonyl-cyclohexen-2-one

1 INTRODUCTION The molecular assembly of one- or multi-dimen-sional aggregation by hydrogen bonds is now an im-portant subject of supramolecular chemistry and crys-tal engineering[1, . Supramolecular structures formed 2]via intermolecular hydrogen bonds X–H…X or C–H…X (X = O, Cl, N, et al.) are very common inorganic compounds[3~12], and they generally possessdifferent properties due to these hydrogen bonds. Concerning about the spectra of benzene-contai-ning…     

Synthesis and Crystal Structure of Spiro[1-bromo(S)-4-(R)-hydroxy- 5-oxa-6-oxo-bicyclo[3.1.0]hexane-2,2''-(3''-diethyl-(-(S)-4''-Cl-benzyloxyphosphonyl-4''-(1R,2S,5R)-menthyloxybutyrolactone)]

The title compound, spiro[1-bromo(S)-4-(R)-hydroxy-5-oxa-6-oxo-bicyclo[3.1.0]-hxane-2,2'-(3'-diethyl-α-(S)-4'-Cl-benzyloxyphosphonyl-4'-(1R,2S,5R)-menthyloxybutyrolactone)] has been synthesized via the tandem asymmetric reaction and it crystallizes in a monoclinic system, space group P21 with a = 11.067(3), b = 12.484(2), c = 12.356(2)(A), β = 101.95°,C29H39BrC1O10P, Mr = 693.93, V= 1670.2(6) (A)3, Z= 2, Dc= 1.380 g/cm3, λ(MoKα) = 0.071073nm, μ = 1.410 mm-1, F(000) = 720, the final R = 0.0570 and wR = 0.0758 for 6190 observed reflections with I ＞ 2σ(I). The structure is characterized by the special combination of biologic phosphonyl group and one cyclopropane as well as two butyrolactones. The intermolecular hydrogen bond between O(3)-H(3A)…O(10) in the crystal lattice has been observed.     

Assay of whole blood (6S)-5-CH3-H4folate using ultra performance liquid chromatography tandem mass spectrometry

Folates act as essential coenzymes in many biological pathways, including the synthesis and methylation of DNA. Low folate concentration in serum and whole blood (WB) is associated with several disease conditions. We describe a stable-isotope-dilution ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for the quantification of (6S)-5-CH(3)-H(4)folate (where H(4)folate is tetrahydrofolate) and non-CH(3)-H(4)folate [sum of HCO-H(4)folate, (6R)-5,10-CH(+)-H(4)folate, (6R)-5,10-CH(2)-H(4)folate, (6S)-H(4)folate, dihydrofolate, and folic acid] in WB. The assay includes a solid-phase extraction procedure after the hemolysis and deconjugation. The method was linear over the concentration range from 0.2 to 200 nmol/L. The limits of detection were 0.40 nmol/L or lower for the folate forms. The interassay coefficients of variation were 7.4% for (6S)-5-CH(3)-H(4)folate and 15.4% for non-CH(3)-H(4)folate. For the folate forms, the recoveries were between 97.1% and 102.7%. Sample preparation caused the generation of artificial folic acid in WB and serum in a dose-dependent manner, which can lead to misinterpretation of the results. The use of antioxidants could not prevent the formation of folic acid. The median fasting WB folate concentrations from 42 nonsupplemented and nonfortified adults were 576 nmol/L (6S)-5-CH(3)-H(4)folate and 73.6 nmol/L non-CH(3)-H(4)folate, and 1,206 nmol/L (6S)-5-CH(3)-H(4)folate and 155 nmol/L non-CH(3)-H(4)folate for 35 adults who had taken 500 μg of folic acid, 50 mg of vitamin B(6), and 500 μg of vitamin B(12) per day orally for 6 months. In conclusion, the UPLC-MS/MS method is fast and has a good sensitivity and selectivity for WB folates. We observed a dose-dependent oxidation of (6S)-H(4)folate, which resulted in the formation of artificial folic acid in serum and WB. To minimize this effect, we recommend a fast sample preparation.     

Co3(RL)2(hfac)6 ladder complex of 5-[4-(N-tert-butyl-N-aminoxyl)phenyl]pyrimidine

5-[4-(N-tert-butyl-N-aminoxyl)phenyl]pyridimine (4NITPhPyrim = RL) forms a 1-D ladder polymer complex with Co(hfac)2 of stoichiometry Co3(RL)2(hfac)6, having antiparallel [Co(II)RL]n linear chains (rails) that are cross-linked by Pyrim-Co(hfac)2-Pyrim rungs. The magnetic behavior above 100 K is consistent with contributions from one high-spin Co(II) ion (the cross-link, S = 3/2) plus two Co-ON units with strongly antiferromagnetic (AFM) metal-radical exchange (each S = 1). The chiT data show an AFM downturn as the temperature drops. Assuming weak exchange along chain portions of the polymer due to poor spin polarization across the phenyl-pyrimidine bond in RL, a linear three-spin (S = 1, 3/2, and 1) fit to the T > 18 K data yields an AFM cross-linker (rung) effective exchange of J(CL)/k = (-)5.3 K = (-)3.7 cm(-)(1). Superexchange (sigma-orbital overlap) is a likely mechanism for the effective AFM exchange between CoON and Co spin sites in the three-spin groupings.     

Addition of Pt(PBu(t)(3)) groups to Ru(5)(CO)(12)(eta(6)-C(6)H(6))(mu(5)-C). Synthesis, structures, and dynamical activity

The reaction of Ru(5)(CO)(12)(eta(6)-C(6)H(6))(mu(5)-C), 7, with Pt(PBu(t)(3))(2) yielded two products Ru(5)(CO)(12)(eta(6)-C(6)H(6))(mu(6)-C)[Pt(PBu(t)(3))], 8, and Ru(5)(CO)(12)(eta(6)-C(6)H(6))(mu(6)-C)[Pt(PBu(t)(3))](2), 9. Compound 8 contains a Ru(5)Pt metal core in an open octahedral structure. In solution, 8 exists as a mixture of two isomers that interconvert rapidly on the NMR time scale at 20 degrees C, DeltaH() = 7.1(1) kcal mol(-1), DeltaS() = -5.1(6) cal mol(-)(1) K(-)(1), and DeltaG(298)(#) = 8.6(3) kcal mol(-1). Compound 9 is structurally similar to 8, but has an additional Pt(PBu(t)(3)) group bridging an Ru-Ru edge of the cluster. The two Pt(PBu(t)(3)) groups in 9 rapidly exchange on the NMR time scale at 70 degrees C, DeltaH(#) = 9.2(3) kcal mol(-)(1), DeltaS(#) = -5(1) cal mol(-)(1) K(-)(1), and DeltaG(298)(#) = 10.7(7) kcal mol(-1). Compound 8 reacts with hydrogen to give the dihydrido complex Ru(5)(CO)(11)(eta(6)-C(6)H(6))(mu(6)-C)[Pt(PBu(t)(3))](mu-H)(2), 10, in 59% yield. This compound consists of a closed Ru(5)Pt octahedron with two hydride ligands bridging two of the four Pt-Ru bonds.     

Synthesis of (5R)- and (5S)-5-Methyl-5, 6-dihydrouridine Derivatives

The hydrogenation of 2′, 3′-O-isopropylidene-5-methyluridine (1) in water over 5% Rh/Al₂O₃ gave (5 R)- and (5 S)-5-methyl-5, 6-dihydrouridine (2) , separated as 5′-O-(p-tolylsulfonyl)- (3) and 5′-O-benzoyl- (5) derivatives by preparative TLC. on silica gel and ether/hexane developments. The diastereoisomeric differentiation at the C(5) chiral centre depends upon the reaction media and the nature of the protecting group attached to the ribosyl moiety. The synthesis of iodo derivatives (5 R)- and (5 S)- 4 is also described. The diastereoisomers 4 were converted into (5 R)- and (5 S)-2′, 3′,-O-isopropylidene-5-methyl-2, 5′-anhydro-5, 6-dihydrouridine (7) .     

Electron attachment to SF5X compounds: SF5C6H5, SF5C2H3, S2F10, and SF5Br, 300-550 K

Rate constants and ion product channels have been measured for electron attachment to four SF5 compounds, SF5C6H5, SF5C2H3, S2F10, and SF5Br, and these data are compared to earlier results for SF6, SF5Cl, and SF5CF3. The present rate constants range over a factor of 600 in magnitude. Rate constants measured in this work at 300 K are 9.9+/-3.0x10(-8) (SF5C6H5), 7.3+/-1.8x10(-9) (SF5C2H3), 6.5+/-2.5x10(-10) (S2F10), and 3.8+/-2.0x10(-10) (SF5Br), all in cm3 s-1 units. SF5- was the sole ionic product observed for 300-550 K, though in the case of S2F10 it cannot be ascertained whether the minor SF4- and SF6- products observed in the mass spectra are due to attachment to S2F10 or to impurities. G3(MP2) electronic structure calculations (G2 for SF5Br) have been carried out for the neutrals and anions of these species, primarily to determine electron affinities and the energetics of possible attachment reaction channels. Electron affinities were calculated to be 0.88 (SF5C6H5), 0.70 (SF5C2H3), 2.95 (S2F10), and 2.73 eV (SF5Br). An anticorrelation is found for the Arrhenius A-factor with exothermicity for SF5- production for the seven molecules listed above. The Arrhenius activation energy was found to be anticorrelated with the bond strength of the parent ion.     

Redox properties of C6S8(n-) and C3S5(n-) (n = 0, 1, 2): stable radicals and unusual structural properties for C-S-S-C bonds

The new anionic carbon sulfides C6S10(2-) and C12S16(2-) are described and crystallographically characterized. The C12S16(2-) anion consists of two C6S8 units connected by an exceptionally long (2.157(12) A) S-S bond. In solution, C12S16(2-) exists in equilibrium with the radical C6S8(-*). The equilibrium constant for radical formation (293 K, THF) is 1.2 x 10(-4) M, as determined by optical spectroscopy at varying concentrations. Radical formation occurs through scission of the S-S bond. On the basis of variable temperature EPR spectra, the thermodynamic parameters of this process are DeltaH = +51.5 +/- 0.5 kJ x mol(-1) and DeltaS = +110 +/- 3 J x mol(-1) x K(-1). C6S10(2-) is an oxidation product of C3S5(2-) and consists of two C3S5 units connected by an S-S bond. The S-S bond length (2.135(4) A) is long, and the CS-SC torsion angle is unusually acute (52.1 degrees ), which is attributed to an attractive interaction between C3S2 rings. The oxidation of (Me4N)2C3S5 occurs at -0.90 V vs Fc+/Fc in MeCN, being further oxidized at -0.22 V. The similarity of the cyclic voltammogram of (Me4N)2C6S10 to that of (Me4N)2C3S5 indicates that C6S10(2-) is the initial oxidation product of C3S5(2-).     

New class of ruthenium sulfide clusters: Ru(4)S(6)(PPh(3))(4), Ru(5)S(6)(PPh(3))(5), and Ru(6)S(8)(PPh(3))(6)

Reaction of RuCl(2)(PPh(3))(3) with S(2)(-) sources yields a family of phosphine-containing Ru-S clusters which have been characterized crystallographically and by MALDI-MS. Ru(4)S(6)(PPh(3))(4) (Ru-Ru(av) = 2.94 A) has idealized T(d)() symmetry whereas Ru(6)S(8)(PPh(3))(6) (Ru-Ru(av) = 2.82 A) adopts the idealized O(h)() symmetry characteristic of Chevrel clusters. Ru(5)S(6)(PPh(3))(5) is formally derived by the addition of Ru(PPh(3)) to one face of Ru(4)S(6)(PPh(3))(4). In terms of its M-S connectivity, the Ru(5)S(6) cluster resembles a fragment of the FeMo cluster in nitrogenase.